Kassim Rida A, Saleh Khaled J, Badra Mohamed, Moran Tim, Esterberg Justin L
Department of Orthopaedics & Clinical Outcome Research Center, University of Minnesota, Minneapolis, MN 55455, USA.
J South Orthop Assoc. 2003 Summer;12(2):103-5.
Thromboembolic disorders are worrisome complications following total hip arthroplasty, and the best way to address such complications is by prevention. Several regimens have been advocated to decrease the risk of thromboembolic disorders. A combination of pharmacologic and nonpharmacologic measures helps reduce the incidence of deep venous thrombosis and, hence, pulmonary embolization.
